Atossa Genetics Announces Publication of Mammary Aspirate Specimen Cytology Test (MASCT) System Clinical Trial Results SEATTLE, WA--(Marketwired - Aug 20, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced the publication of a peer-reviewed paper titled "A phase I safety...